CLINICAL_TRIALS
trial_result
· 2020-05-08
Clinical Trial Update: Triple Therapy With Tegoprazan in H. Pylori Positive Patients [Phase 3]
Summary
Phase 3 clinical trial update evaluating triple therapy with tegoprazan in Helicobacter Pylori infection has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: HK inno.N Corporation | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED